Get the Stockscreener App
44.78
6.39%
2.69
Scholar Rock Holding Corp stock is traded at $44.78, with a volume of 2.44M.
It is up +6.39% in the last 24 hours and up +60.73% over the past month.
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.
See More
Previous Close:
$42.09
Open:
$41.76
24h Volume:
2.44M
Relative Volume:
1.19
Market Cap:
$4.19B
Revenue:
$47.30M
Net Income/Loss:
$-225.97M
P/E Ratio:
-22.73
EPS:
-1.97
Net Cash Flow:
$-188.86M
1W Performance:
+6.67%
1M Performance:
+60.73%
6M Performance:
+439.52%
1Y Performance:
+152.28%
1-Day Range:
$41.53
$45.84
1-Week Range:
$40.22
$45.84
52-Week Range:
$6.76
$46.19
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Name
Scholar Rock Holding Corp
Sector
Industry
Phone
857-259-3860
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
44.78 | 4.19B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-24 | Reiterated | H.C. Wainwright | Buy |
| Oct-07-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-24 | Initiated | Raymond James | Strong Buy |
| Oct-25-23 | Upgrade | Jefferies | Hold → Buy |
| Apr-03-23 | Resumed | Piper Sandler | Overweight |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Jul-12-22 | Initiated | Truist | Buy |
| Mar-23-22 | Initiated | H.C. Wainwright | Buy |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | Credit Suisse | Outperform |
| Jan-06-21 | Initiated | JP Morgan | Overweight |
| Mar-12-20 | Initiated | Robert W. Baird | Outperform |
View All
Scholar Rock Holding Corp Stock (SRRK) Latest News
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 6,269 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Stake Boosted by Wellington Management Group LLP - MarketBeat
Scholar Rock's SWOT analysis: biotech stock poised for pivotal trial results - Investing.com
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Bought by BNP Paribas Financial Markets - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Scholar Rock Grants $9.5M in Equity Awards to Attract Top Talent in Strategic Growth Move - StockTitan
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Point72 Asset Management L.P. Increases Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
The Manufacturers Life Insurance Company Trims Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Certain Stock Options of Scholar Rock Holding Corporation are subject to a Lock-Up Agreement Ending on 8-DEC-2024. - Marketscreener.com
SRRK Stock Soars to 52-Week High, Hits $43.48 Amidst 146.5% Annual Surge By Investing.com - Investing.com South Africa
SRRK Stock Soars to 52-Week High, Hits $43.48 Amidst 146.5% Annual Surge - Investing.com Canada
Intech Investment Management LLC Invests $202,000 in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Intech Investment Management LLC Acquires New Stake in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock (NASDAQ:SRRK) Hits New 1-Year HighHere's Why - MarketBeat
Fmr LLC Boosts Stock Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock's SWOT analysis: promising pipeline drives stock potential - Investing.com
Redmile Group LLC Sells 214,246 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Why Is Scholar Rock Holding Corporation (SRRK) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Insider Monkey
Scholar Rock Holding Co. (NASDAQ:SRRK) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Sold by Eventide Asset Management LLC - MarketBeat
Fisher Asset Management LLC Purchases 628,186 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
HC Wainwright Predicts Stronger Earnings for Scholar Rock - Defense World
FY2026 EPS Forecast for Scholar Rock Increased by Analyst - MarketBeat
FY2024 Earnings Forecast for Scholar Rock Issued By Wedbush - MarketBeat
Scholar Rock's chief medical officer sells $315,771 in stock - Investing.com India
Scholar Rock holding sees $15.76m in stock sales by major shareholders - Investing.com Canada
Scholar Rock set for BLA, among 14 phase III wins in October - BioWorld Online
Biotech Alert: Searches spiking for these stocks today - TipRanks
Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
Wedbush Forecasts Strong Price Appreciation for Scholar Rock (NASDAQ:SRRK) Stock - Defense World
Scholar Rock's chief medical officer sells $315,771 in stock By Investing.com - Investing.com Nigeria
Scholar Rock (NASDAQ:SRRK) Price Target Raised to $50.00 at HC Wainwright - MarketBeat
Scholar Rock shares surge 26% as rival Biohaven misses SMA study goal - TradingPedia
SRRK stock soars to 52-week high, touches $40 mark By Investing.com - Investing.com South Africa
Quest Partners LLC Trims Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Biohaven’s SMA Trial Miss Bolsters Scholar Rock Stock: Analysts Give Verdicts, Retail Watches Closely - MSN
SRRK stock soars to 52-week high, touches $40 mark - Investing.com
Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study - Inkl
Why Scholar Rock shares are surging By Investing.com - Investing.com Nigeria
Why Scholar Rock shares are surging - Investing.com
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday - Benzinga
Scholar Rock (NASDAQ:SRRK) Stock Price Up 9.2%Still a Buy? - MarketBeat
FY2024 EPS Estimates for Scholar Rock Cut by HC Wainwright - Defense World
What is Wedbush’s Forecast for Scholar Rock FY2024 Earnings? - Defense World
Redmile Group, LLC Expands Stake in Scholar Rock Holding Corp - GuruFocus.com
OrbiMed Advisors LLC Adjusts Stake in Scholar Rock Holding Corp - GuruFocus.com
Analysts Set Expectations for Scholar Rock FY2024 Earnings - MarketBeat
FY2028 Earnings Forecast for Scholar Rock Issued By Wedbush - MarketBeat
HC Wainwright Comments on Scholar Rock Q3 Earnings - MarketBeat
Scholar Rock chief medical officer sells $63k in stock By Investing.com - Investing.com Australia
Scholar Rock Holding Corp Stock (SRRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):